| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Kolte AM, Olsen LR, Mikkelsen EM, et al. Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss[J]. Hum Reprod, 2015, 30(4): 777-782. DOI: 10.1093/humrep/dev014.
|
| [7] |
He L, Wang T, Xu H, et al. Prevalence of depression and anxiety in women with recurrent pregnancy loss and the associated risk factors[J]. Arch Gynecol Obstet, 2019, 300(4): 1061-1066. DOI: 10.1007/s00404-019-05264-z.
|
| [8] |
Koert E, Malling G, Sylvest R, et al. Recurrent pregnancy loss: couples′ perspectives on their need for treatment, support and follow up[J]. Hum Reprod, 2019, 34(2): 291-296. DOI: 10.1093/humrep/dey362.
|
| [9] |
Lu D, Huang Y, Kong Y, et al. Gut microecology: why our microbes could be key to our health[J]. Biomed Pharmacother, 2020, 131: 110784. DOI: 10.1016/j.biopha.2020.110784.
|
| [10] |
Federici M. Gut microbiome and microbial metabolites: a new system affecting metabolic disorders[J]. J Endocrinol Invest, 2019, 42(9): 1011-1018. DOI: 10.1007/s40618-019-01022-9.
|
| [11] |
Browne HP, Neville BA, Forster SC, et al. Transmission of the gut microbiota: spreading of health[J]. Nat Rev Microbiol, 2017, 15(9): 531-543. DOI: 10.1038/nrmicro.2017.50.
|
| [12] |
El Aidy S, Dinan TG, Cryan JF. Gut microbiota: the conductor in the orchestra of immune-neuroendocrine communication[J]. Clin Ther, 2015, 37(5): 954-967. DOI: 10.1016/j.clinthera.2015.03.002.
|
| [13] |
Salah M, Azab M, Ramadan A, et al. New insights on obesity and diabetes from gut microbiome alterations in Egyptian adults[J]. Omics, 2019, 23(10): 477-485. DOI: 10.1089/omi.2019.0063.
|
| [14] |
Xu H, Liu M, Cao J, et al. The dynamic interplay between the gut microbiota and autoimmune diseases[J]. J Immunol Res, 2019, 2019: 7546047. DOI: 10.1155/2019/7546047.
|
| [15] |
Scheithauer T, Rampanelli E, Nieuwdorp M, et al. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes[J]. Front Immunol, 2020, 11: 571731. DOI: 10.3389/fimmu.2020.571731.
|
| [16] |
Cavalcante MB, Sarno M, Peixoto AB, et al. Obesity and recurrent miscarriage: a systematic review and Meta-analysis[J]. J Obstet Gynaecol Res, 2019, 45(1): 30-38. DOI: 10.1111/jog.13799.
|
| [17] |
Eapen A, Hayes ET, McQueen DB, et al. Mean differences in maternal body mass index and recurrent pregnancy loss: a systematic review and Meta-analysis of observational studies[J]. Fertil Steril, 2021, 116(5): 1341-1348. DOI: 10.1016/j.fertnstert.2021.06.019.
|
| [18] |
Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance[J]. Ann NY Acad Sci, 2020, 1461(1): 37-52. DOI: 10.1111/nyas.14107.
|
| [19] |
Lim YY, Lee YS, Ooi D. Engineering the gut microbiome for treatment of obesity: a review of current understanding and progress[J]. Biotechnol J, 2020, 15(10): e2000013. DOI: 10.1002/biot.202000013.
|
| [20] |
Sharma M, Li Y, Stoll ML, et al. The epigenetic connection between the gut microbiome in obesity and diabetes[J]. Front Genet, 2019, 10: 1329. DOI: 10.3389/fgene.2019.01329.
|
| [21] |
Aoun A, Darwish F, Hamod N. The influence of the gut microbiome on obesity in adults and the role of probiotics, prebiotics, and synbiotics for weight loss[J]. Prev Nutr Food Sci, 2020, 25(2): 113-123. DOI: 10.3746/pnf.2020.25.2.113.
|
| [22] |
Insenser M, Murri M, Del Campo R, et al. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity[J]. J Clin Endocrinol Metab, 2018, 103(7): 2552-2562. DOI: 10.1210/jc.2017-02799.
|
| [23] |
Shirvani RS, Nikkhah A, Orvatinia M, et al. Gut microbiota: a perspective of precision medicine in endocrine disorders[J]. J Diabetes Metab Disord, 2020, 19(2): 1827-1834. DOI: 10.1007/s40200-020-00593-2.
|
| [24] |
Zhao X, Jiang Y, Xi H, et al. Exploration of the relationship between gut microbiota and polycystic ovary syndrome (PCOS): a review[J]. Geburtshilfe Frauenheilkd, 2020, 80(2): 161-171. DOI: 10.1055/a-1081-2036.
|
| [25] |
Yurtdaş G, Akdevelioǧlu Y. A new approach to polycystic ovary syndrome: the gut microbiota[J]. J Am Coll Nutr, 2020, 39(4): 371-382. DOI: 10.1080/07315724.2019.1657515.
|
| [26] |
Corrie L, Gulati M, Vishwas S, et al. Combination therapy of curcumin and fecal microbiota transplant: potential treatment of polycystic ovarian syndrome[J]. Med Hypotheses, 2021, 154: 110644. DOI: 10.1016/j.mehy.2021.110644.
|
| [27] |
Darbandi M, Rezaeian S, Dianatinasab M, et al. Prevalence of gestational diabetes and its association with stillbirth, preterm birth, macrosomia, abortion and cesarean delivery: a national prevalence study of 11 provinces in Iran[J]. J Prev Med Hyg, 2021, 62(4): E885-E891. DOI: 10.15167/2421-4248/jpmh2021.62.4.1788.
|
| [28] |
Duan L, An X, Zhang Y, et al. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus[J]. Biomed Pharmacother, 2021, 142: 112094. DOI: 10.1016/j.biopha.2021.112094.
|
| [29] |
Craciun CI, Neag MA, Catinean A, et al. The relationships between gut microbiota and diabetes mellitus, and treatments for diabetes mellitus[J]. Biomedicines, 2022, 10(2): 308. DOI: 10.3390/biomedicines10020308.
|
| [30] |
Salgaço MK, Oliveira L, Costa GN, et al. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus[J]. Appl Microbiol Biotechnol, 2019, 103(23-24): 9229-9238. DOI: 10.1007/s00253-019-10156-y.
|
| [31] |
Li WZ, Stirling K, Yang JJ, et al. Gut microbiota and diabetes: from correlation to causality and mechanism[J]. World J Diabet, 2020, 11(7): 293-308. DOI: 10.4239/wjd.v11.i7.293.
|
| [32] |
Docimo G, Cangiano A, Romano RM, et al. The human microbiota in endocrinology: implications for pathophysiology, treatment, and prognosis in thyroid diseases[J]. Front Endocrinol (Lausanne), 2020, 11: 586529. DOI: 10.3389/fendo.2020.586529.
|
| [33] |
Dong AC, Morgan J, Kane M, et al. Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and Meta-analysis[J]. Fertil Steril, 2020, 113(3): 587.e1-600.e1. DOI: 10.1016/j.fertnstert.2019.11.003.
|
| [34] |
Zhou F, Wang X, Wang L, et al. Genetics, epigenetics, cellular immunology, and gut microbiota: emerging links with Graves′ disease[J]. Front Cell Dev Biol, 2021, 9: 794912. DOI: 10.3389/fcell.2021.794912.
|
| [35] |
Huo D, Cen C, Chang H, et al. Probiotic bifidobacterium longum supplied with methimazole improved the thyroid function of Graves′ disease patients through the gut-thyroid axis[J]. Commun Biol, 2021, 4(1): 1046. DOI: 10.1038/s42003-021-02587-z.
|
| [36] |
Liu S, An Y, Cao B, et al. The composition of gut microbiota in patients bearing Hashimoto′s thyroiditis with euthyroidism and hypothyroidism[J]. Int J Endocrinol, 2020, 2020: 5036959. DOI: 10.1155/2020/5036959.
|
| [37] |
Zhao F, Feng J, Li J, et al. Alterations of the gut microbiota in Hashimoto′s thyroiditis patients[J]. Thyroid, 2018, 28(2): 175-186. DOI: 10.1089/thy.2017.0395.
|
| [38] |
Wang Y, Meng Z, Pei J, et al. Anxiety and depression are risk factors for recurrent pregnancy loss: a nested case-control study[J]. Health Qual Life Outcom, 2021, 19(1): 78. DOI: 10.1186/s12955-021-01703-1.
|
| [39] |
Barandouzi ZA, Starkweather AR, Henderson WA, et al. Altered composition of gut microbiota in depression: a systematic review[J]. Front Psychiat, 2020, 11: 541. DOI: 10.3389/fpsyt.2020.00541.
|
| [40] |
Mynarska E, Gadzinowska J, Tokarek J, et al. The role of the microbiome-brain-gut axis in the pathogenesis of depressive disorder[J]. Nutrients, 2022, 14(9): 1921. DOI: 10.3390/nu14091921.
|
| [41] |
Evrensel A, Tarhan KN. Emerging role of gut-microbiota-brain axis in depression and therapeutic implication[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2021, 106: 110138. DOI: 10.1016/j.pnpbp.2020.110138.
|
| [42] |
Nikolova V, Zaidi SY, Young AH, et al. Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: systematic review and Meta-analysis[J]. Ther Adv Psychopharmacol, 2019, 9: 2045125319859963. DOI: 10.1177/2045125319859963.
|
| [43] |
|